Annovis Bio Inc (ANVS) — Cash Flow-to-Debt Ratio
Annovis Bio Inc (ANVS) has a Cash Flow-to-Debt Ratio of -2.11x as of December 2025, meaning its operating cash flow of $-8.93 Million could theoretically repay -2% of its total liabilities ($4.23 Million) in one year. Check cash flow reinvestment rate of Annovis Bio Inc to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Annovis Bio Inc Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Annovis Bio Inc across 13 annual periods. Also explore Annovis Bio Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Annovis Bio Inc (2009–2025)
Year-by-year debt coverage analysis for Annovis Bio Inc. For market capitalisation and broader financial context, see ANVS market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6056.13x | $-25.62 Billion | $4.23 Million | ▼ -27.7% |
| 2024 | -4741.16x | $-21.89 Billion | $4.62 Million | ▼ -212941.6% |
| 2023 | -2.23x | $-39.97 Million | $17.96 Million | ▲ +1.0% |
| 2022 | -2.25x | $-17.31 Million | $7.70 Million | ▲ +62.9% |
| 2021 | -6.06x | $-9.13 Million | $1.51 Million | ▲ +11.7% |
| 2020 | -6.87x | $-3.97 Million | $578.38K | ▼ -13865.2% |
| 2019 | -0.05x | $-476.54K | $9.69 Million | ▲ +32.7% |
| 2018 | -0.07x | $-558.61K | $7.64 Million | ▲ +0.4% |
| 2017 | -0.07x | $-537.48K | $7.32 Million | ▲ +99.1% |
| 2012 | -8.10x | $-1.41 Million | $174.36K | ▼ -1808.1% |
| 2011 | -0.42x | $-3.01 Million | $7.09 Million | ▼ -33.0% |
| 2010 | -0.32x | $-1.77 Million | $5.55 Million | ▲ +96.3% |
| 2009 | -8.56x | $-389.23K | $45.49K | — |